Life Healthcare : UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

LIFE HEALTHCARE GROUP LIMITED

蓮 和 醫 療 健 康 集 團 有 限 公 司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 928)

UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS

This announcement is made pursuant to Rule 13.09 of the Rules Governing the Listing of Securities (the ''Listing Rules'') on The Stock Exchange of Hong Kong Limited and the Inside Information Provisions (as defined under the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the ''SFO'').

The board of directors (the ''Board'') of Life Healthcare Group Limited (the ''Company''), has noted the increases in price and trading volume of the shares of the Company today.

The Company wishes to inform its shareholders and potential investors that as at the date of this announcement, the Company is at a preliminary stage of discussing possible transactions related to healthcare services business. The Company has not entered into any legally binding agreement in relation to such possible transactions. The Company will comply with the relevant requirements under the Listing Rules in the event that any announcement has to be made pursuant to the Listing Rules.

Having made such enquiry with respect to the Company as is reasonable in the circumstances, save as disclosed in this announcement, the Board is not aware of any reasons for these price and volume movements or any information that requires disclosure under the Listing Rules and Part XIVA of the SFO.

- 1 -

This announcement is made by the order of the Company. The Board collectively and individually accepts responsibility for the accuracy of this announcement.

Shareholders and potential investors of the Company are advised to exercise caution when dealing in the securities of the Company.

By order of the Board

Life Healthcare Group Limited

Man Wai Lun

Executive Director

Hong Kong, 30 January 2020

As at the date of this announcement, the Board comprises:

Executive Directors:	Independent non-executive Directors:
Mr. Xu Xueping (Chairman)	Mr. Liu Xinghua
Mr. Man Wai Lun	Mr. Zheng Chunlei
Mr. Yang Zhiying	Mr. Cheng Chun Man
Non-executive Director:
Ms. Shan Hua

- 2 -